美国 FDA 解除对 Novavax 的 COVID 流感复合疫苗的临床试验限制

Reuters
11 Nov 2024

((自动化翻译由路透提供,请见免责声明 ))

路透11月11日 - Novavax公司周一表示,美国食品和药物管理局已经取消了对该公司 COVID-流感疫苗及其独立流感疫苗后期临床试验的限制。

该公司股价在盘前交易中上涨了约9%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10